CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Althea Group Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Althea Group Holdings Ltd
Suite 2, Level 37, 360 Elizabeth Street,
Phone: +61 300702020p:+61 300702020 MELBOURNE, VIC  3000  Australia Ticker: AGHAGH
Business Summary
Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products. The Company operates through two business units: Althea and Peak Processing Solutions. Althea, the Company’s pharmaceutical business, offers a comprehensive range of cannabis-based medicines which are made available to patients through prescription. Peak Processing Solutions, the Company’s recreational cannabis business, produces legal cannabis products purchased by adult consumers in retail stores. The Company operates in highly regulated and legal cannabis markets across the world, with burgeoning operations in North America, Europe and Australia. The Company’s segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate).

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board VaughanWebber 8/29/2024 8/29/2024
Chief Executive Officer, Managing Director, Executive Director JoshuaFegan
Company Secretary RobertMeissner 4/1/2019 4/1/2019
Independent Non-Executive Director AlanBoyd 68
Independent Non-Executive Director PenelopeDobson

General Information
Outstanding Shares: 406,503,376 (As of 6/30/2024)
Shareholders: 9,242
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024